Table 2 Bland-Altman analysis of the differences in GL, EF50 and Cdyn.
From: Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice
| Â | Â | Early AR | Cholinergic AR | ||
|---|---|---|---|---|---|
Group | Parameters | Mean ± SD (95% CI) | Upper limit (95% CI) Lower limit (95% CI) | Mean ± SD (95% CI) | Upper limit (95% CI) Lower limit (95% CI) |
Allergic | EF50 vs. GL | -27.6 ± 17.8 (-42.6/-12.7) | 8.0 (-17.8/33.9) -63.3 (-89.2/-37.5) | -0.7 ± 0.7 (-1.3/0.1) | 0.7 (-0.3/1.8) -2.1 (-3.2/-1.1) |
|  | GL vs. Cdyn | 13.3 ± 21.9 (-5/31.7) | 57.1 (25.4/88.8) -30.5 (-62.2/1.2) | 0 ± 0.2 (-0.2/0.2) | 0.4 (0.1/0.7) -0.4 (-0.7/-0.1) |
|  | EF50 vs. Cdyn | -14.3 ± 29.5 (-39/10.3) | 44.7 (2/87.4) -73.3 (-116/-30.6) | -0.7 ± 0.9 (-1.4/0) | 1 (-0.2/2.3) -2.5 (-3.7/-1.2) |
Control | EF50 vs. GL | -2.4 ± 9.5 (-10.4/5.5) | 16.6 (2.8/30.5) -21.5 (-35.3/-7.7) | -2.9 ± 3.3 (-5.7/-0.2) | 3.7 (-1.1/8.5) -9.5 (-14.3/-4.7) |
|  | GL vs. Cdyn | -3.7 ± 10.4 (-12.2/5.1) | 17.2 (2.1 to 32.3) -24.6 (-39.7/-9.4) | 1.4 ± 1.8 (-0.2/2.9) | 5 (2.4/7.7) -2.3 (-4.9/0.4) |
|  | EF50 vs. Cdyn | -6.1 ± 9.1 (-13.8/-1.5) | 12.2 (-1.1/25.4) -24.4 (-37.6/-11.2) | -1.5 ± 3.5 (-4.5/1.4) | 5.5 (0.4/10.7) -8.6 (-13.8/-3.5) |